Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families-Reference-Cited by-同舟云学术

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

Published:2012-03-13 Issue:8 Volume:106 Page:1460-1463
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Osher D J,De Leeneer K,Michils G,Hamel N,Tomiak E,Poppe B,Leunen K,Legius E,Shuen A,Smith E,Arseneau J,Tonin P,Matthijs G,Claes K,Tischkowitz M D,Foulkes W D

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201287.pdf

Reference10 articles.

1. Banerjee S, Kaye SB, Ashworth A (2010) Making the best of PARP inhibitors in ovarian cancer. Nat Rev Clin Oncol 7 (9): 508–519

2. Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474 (7353): 609–615

3. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA (1999) The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 65 (4): 1021–1029

4. Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N (2011) Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43 (9): 879–882

5. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42 (5): 410–414

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families;Journal of Personalized Medicine;2024-08-16

2. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

3. The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population;Genes;2023-06-24

4. Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases;Frontiers in Oncology;2023-03-08

5. In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins;ACS Omega;2023-03-08